A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
Acebutolol has been studied across 13 research domains including ❤️ Cardiovascular, 🔥 Metabolic, 😴 Sleep, 🧠 Focus & Attention, 🫘 Kidney. The primary research focus is ❤️ Cardiovascular with 56% of studies addressing this area.
The following compounds share molecular targets with Acebutolol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Acebutolol is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.